A carregar...
The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy
Recent work suggests the selective Cox-2 inhibitor celecoxib delays progression to androgen independence in hormone sensitive prostate cancer (HSPC) through inhibition of the androgen receptor (AR) and ErbB signaling. However, human studies examining its effect on delaying disease progression while...
Na minha lista:
| Publicado no: | Am J Clin Exp Urol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6055075/ https://ncbi.nlm.nih.gov/pubmed/30038944 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|